David Thomas Evans Buys 150,000 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO David Thomas Evans bought 150,000 shares of Cardlytics stock in a transaction that occurred on Friday, May 15th. The shares were acquired at an average price of $0.65 per share, with a total value of $97,500.00. Following the completion of the acquisition, the chief financial officer directly owned 267,930 shares of the company’s stock, valued at $174,154.50. This represents a 127.19% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

David Thomas Evans also recently made the following trade(s):

  • On Monday, May 18th, David Thomas Evans bought 50,000 shares of Cardlytics stock. The shares were acquired at an average price of $0.63 per share, with a total value of $31,500.00.

Cardlytics Stock Performance

Shares of NASDAQ:CDLX opened at $0.73 on Thursday. The stock has a market capitalization of $41.77 million, a price-to-earnings ratio of -0.41 and a beta of 0.67. Cardlytics, Inc. has a 1-year low of $0.57 and a 1-year high of $3.28. The company has a 50 day moving average price of $0.87 and a 200 day moving average price of $1.04.

Cardlytics (NASDAQ:CDLXGet Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The firm had revenue of $56.10 million during the quarter, compared to analysts’ expectations of $54.46 million. Cardlytics had a negative net margin of 46.03% and a negative return on equity of 956.56%. On average, sell-side analysts expect that Cardlytics, Inc. will post -0.11 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CDLX. XTX Topco Ltd lifted its position in Cardlytics by 143.5% in the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after buying an additional 50,663 shares in the last quarter. Marshall Wace LLP purchased a new stake in Cardlytics in the 2nd quarter worth approximately $59,000. Jane Street Group LLC lifted its position in Cardlytics by 263.0% in the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after buying an additional 117,687 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in Cardlytics in the 3rd quarter worth approximately $26,000. Finally, Thompson Davis & CO. Inc. purchased a new stake in Cardlytics in the 3rd quarter worth approximately $111,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Analysts Set New Price Targets

CDLX has been the subject of several research analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. Bank of America restated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Evercore set a $1.00 price target on shares of Cardlytics in a research report on Friday, March 6th. Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Finally, Lake Street Capital set a $1.00 price target on shares of Cardlytics in a research report on Friday, May 8th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Sell” and a consensus price target of $1.00.

View Our Latest Research Report on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

See Also

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.